Osimertinib,gefitinib
astrazeneca
['flaura']
 i agree- pfs is a duh endpoint for chemo/tki vs tki comparison here and os benefit key to see in flaura2 for all that added time on chemo w qol detriment - maybe for ?high risk subsets 
Thoracic/precision oncology 🇭🇺🇺🇸